This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

'RealMoney' Radio Recap: Ghosts of Rallies Past

Let go of the past, Jim Cramer told listeners Friday on his "RealMoney" radio show .

Tech stalwarts such as Dell (DELL - Get Report), Cisco (CSCO - Get Report), Sun Microsystems (SUNW) and Oracle (ORCL - Get Report) have seen their best years, he said, and it's time to move on to find the next Dell, the next Cicso, the next Sun and the next Oracle.

What these stocks have in common is little to no growth, said Cramer, and growth is what Wall Street likes. So, waiting for a better time to sell means capital is being tied up when it could be redeployed elsewhere. There are so many stocks that are better, said Cramer. "It makes no sense to hold them."

If you have to, sell small amounts over time, he said, until the positions are gone. You can always buy them back if something changes, he said.

Cramer likes Intel (INTC - Get Report) and Microsoft (MSFT - Get Report) better than Dell. Broadcom (BRCM - Get Report) is better than Cisco, he said. Cramer would rather own SAP (SAP - Get Report) or Microsoft than Oracle. As for Sun Microsystems, that "sector is dead," he said.

Cramer, Unstumped

Stocks Under $10 co-author David Peltier joined Cramer to talk about stocks from Thursday's "Stump Cramer" segment.

Of HMS Holdings (HMSY - Get Report), Peltier said he preferred Allscripts Healthcare Solutions (MDRX - Get Report). Cramer agreed.

Peltier said MainSource Financial Group (MSFG - Get Report) lost its CFO in October, and he would wait to see "how the new CFO does."

Cramer agreed, saying the CFO's departure is "perhaps a red flag."

Peltier said Anadys Pharmaceuticals (ANDS) was well-capitalized with enough cash to last four years. But the company only had $2 million in revenue last quarter and is just beginning human trials, he said. The stock is up big this year, so it could be a risky situation.

Cramer said Anadys sounded interesting, and he recommended monitoring the situation for further developments in the human trials.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
DELL $0.00 0.00%
DYN $33.02 -1.10%
APC $90.32 1.10%
BRCM $45.04 0.31%
CI $124.92 -0.26%

Markets

DOW 17,791.10 -137.10 -0.76%
S&P 500 2,076.84 -12.62 -0.60%
NASDAQ 4,908.6610 -30.6660 -0.62%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs